Indications
Transplantation
- Acute Lung Transplant Rejection (Acute Cellular Lung Transplant Rejection) (see Acute Lung Transplant Rejection, [[Acute Lung Transplant Rejection]])
- Conditioning for Bone Marrow Transplantation (see Bone Marrow Transplant, [[Bone Marrow Transplant]])
- Conditioning for Renal Transplantation (see Renal Transplant, [[Renal Transplant]])
- Conditioning for Islet Cell Transplantation
Other
- Chronic Lymphocytic Leukemia (CLL) (see Chronic Lymphocytic Leukemia, [[Chronic Lymphocytic Leukemia]])
- Cutaneous T-Cell Lymphoma (see Lymphoma, [[Lymphoma]])
- T-Cell Lymphoma (see Lymphoma, [[Lymphoma]])
Pharmacology
- Anti-CD52 Monoclonal Antibody: binds to CD52 on mature lymphocytes, targeting them for destruction
- However, does not bind to stem cells from which lymphocytes are derived
Metabolism
- xxx
Administration
- xxx
Dose Adjustment
- Hepatic
- Renal
Adverse Effects
Other Adverse Effects
- Cytokine Release Syndrome (see Cytokine Release Syndrome, [[Cytokine Release Syndrome]])
References
- xxx